The management of intermediate coronary lesions, defined by a diameter stenosis of 40% to 70%, continues to be a therapeutic dilemma for cardiologists. The 2-dimensional representation of the arterial lesion provided by angiography is limited in distinguishing intermediate lesions that require stenting from those that simply need appropriate medical therapy. In the era of drug-eluting stents, some might propose that stenting all intermediate coronary lesions is an appropriate solution. However, the possibility of procedural complications such as coronary dissection, no reflow phenomenon, in-stent restenosis, and stent thrombosis requires accurate stratification of patients with intermediate coronary lesions to appropriate therapy. Intravascular ultrasound (IVUS) and fractional flow reserve index (FFR) provide anatomic and functional information that can be used in the catheterization laboratory to designate patients to the most appropriate therapy. The purpose of this review is to discuss the critical information obtained from IVUS and FFR in guiding treatment of patients with intermediate coronary lesions. In addition, the importance of IVUS and FFR in the management of patients with serial stenosis, bifurcation lesions, left main disease, saphenous vein graft disease, and acute coronary syndrome will be discussed. (J Am Coll Cardiol 2007;49:839-48)
The management of intermediate coronary lesions, defined by a diameter stenosis of 40% to 70%, continues to be a therapeutic dilemma for cardiologists. The 2-dimensional representation of the arterial lesion provided by angiography is limited in distinguishing intermediate lesions that require stenting from those that simply need appropriate medical therapy. In the era of drug-eluting stents, some might propose that stenting all intermediate coronary lesions is an appropriate solution. However, the possibility of procedural complications such as coronary dissection, no reflow phenomenon, in-stent restenosis, and stent thrombosis requires accurate stratification of patients with intermediate coronary lesions to appropriate therapy. Intravascular ultrasound (IVUS) and fractional flow reserve index (FFR) provide anatomic and functional information that can be used in the catheterization laboratory to designate patients to the most appropriate therapy. The purpose of this review is to discuss the critical information obtained from IVUS and FFR in guiding treatment of patients with intermediate coronary lesions. In addition, the importance of IVUS and FFR in the management of patients with serial stenosis, bifurcation lesions, left main disease, saphenous vein graft disease, and acute coronary syndrome will be discussed. An intermediate coronary lesion on angiography is defined as a luminal narrowing with a diameter stenosis Ն40% but Յ70%. Assessment of a coronary lesion with intermediate severity continues to be a challenge for cardiologists. In the current era of drug-eluting stents (DES), when percutaneous coronary revascularization is achieved with high success, a low complication rate, and excellent long-term patency (1, 2) , it might be tempting to treat all suspect lesions with implantation of a DES. However, there are still procedural complications associated with angioplasty, the inherent risk of restenosis, and late stent thrombosis.
Although it is preferable to have objective evidence of myocardial ischemia before proceeding with percutaneous coronary revascularization, this is not always feasible or completely reliable. Selective coronary angiography is accepted as the standard for determining the presence and extent of epicardial coronary artery disease (CAD). All measures of noninvasive assessment of myocardial ischemia are compared with the presence on angiography of a focal stenosis Ͼ50% diameter. This cutoff is based on animal studies and human clinical correlations that demonstrate functional significance (the induction of ischemia) with the anatomic presence of a 50% diameter stenosis (3) . However, there is significant interobserver and intra-observer variability in interpretation of the severity of stenoses on coronary angiography (4 -6) . In addition, cross-sectional anatomic imaging obtained from histopathological specimens (7) (8) (9) (10) (11) and intravascular ultrasound (IVUS) (12) (13) (14) (15) have highlighted limitations of coronary angiography. Owing to the increased sensitivity of IVUS in identifying disease and its close correlation with pathology, IVUS has become the more accurate standard for defining the anatomy of atherosclerosis in vivo.
There are 2 methods available in the cardiac catheterization laboratory to determine the physiologic significance of a coronary stenosis that are distinct from the anatomic visualization provided by IVUS. These methods rely on the decrease in intra-arterial pressure or flow induced by a functionally significant stenosis to determine whether an intermediate lesion is producing ischemia. At the current time, coronary pressure wire-derived fractional flow reserve (FFR) has supplanted Doppler wire-derived coronary flow reserve (CFR) as the preferred method to assess the physiologic significance of a coronary stenosis. This review will discuss the challenges involved in the assessment and management of a patient with an intermediate lesion. It will focus on the 2 most commonly used methods for assessment of intermediate coronary lesions: IVUS and FFR (Table 1) .
Limitations of Angiography
Histopathological studies have demonstrated that angiographic evidence of stenosis is usually not detected until the cross-sectional area of plaque approaches 40% to 50% of the total cross-sectional area of the vessel (16 -18) . The outer wall of the artery, encompassed by the external elastic membrane (EEM), enlarges to accommodate the growing plaque. This process of compensatory dilatation seems to be limited. When the plaque area exceeds 40% to 50% of the EEM area, the plaque begins to encroach upon the lumen. It is only then that an angiogram might reveal minimal luminal narrowing (19, 20) . A minority of angiographic stenoses might develop by a process of narrowing of the EEM without the presence of a large amount of plaque, a process called negative remodeling (21, 22) .
Similar to a low power histologic cross section, IVUS can identify the presence and extent of plaque and the area of the EEM in vivo, thereby making it more sensitive than angiography (7) (8) (9) (10) (11) (12) 14, 15, 17, 23) . In addition, angiography provides only limited information regarding the composition of the coronary plaque or the degree of calcification (17,24 -26) . Similar to a flashlight projection of a tube in 3-dimensional space, an angiogram is a 2-dimensional X-ray projection of the arterial lumen along the length of the vessel. Stenoses might be incorrectly assessed owing to tortuosity or angulation of the vessels, artery overlap, a short "napkin-ring stenosis," X-ray beam angulation that is not perpendicular to the stenosis, or contrast streaming or separation as it enters an ectatic area. The extent of stenosis is judged by comparison with a reference segment that theoretically is free of disease. However, the reference segment itself often has significant disease as demonstrated by histopathology or IVUS (26) . In addition, significant intra-and inter-observer variability exists in the assessment of coronary stenoses (27) . Although the advent of quantitative coronary angiography (QCA) has reduced interobserver variability, it has not improved the accuracy of coronary angiography to determine the severity of coronary lesions.
IVUS
Intravascular ultrasound is a catheter-based technique that provides tomographic images perpendicular to the length of the coronary arteries. High-resolution cross-sectional images of the coronary lumen and the coronary arterial wall can be visualized in real time, and computer-generated reconstruction allows for longitudinal and 3-dimensional visualization of the coronary artery (Fig. 1) . Intravascular ultrasound is simple to perform, and its use is associated with very low complication rates (28) , even in the setting of acute myocardial infarction (AMI) (29) .
Intravascular ultrasound can segregate lesions according to whether they appear stable versus unstable on the basis of the ultrasound grayscale reflectance of the tissue (30) . Stable plaques have more fibrous tissue or calcification, whereas an unstable plaque has mobile echoes consistent with thrombus or necrotic material and usually is associated with large atheroma (30) . The presence of a plaque with an echolucent central core and a thin fibrous capsule, the so-called "vulnerable plaque," can also be identified by IVUS. Whether these lesions should be treated by percutaneous coronary intervention (PCI) versus medical therapy has not been elucidated by clinical trials.
The advent of radiofrequency signal analysis and elastography techniques might in the future provide incremental clinical information regarding the exact histologic composition of atherosclerotic plaques and possibly their vulnerability to rupture (31); however, there is no convincing evidence that so-called "virtual histology" adds any information beyond the traditional IVUS grayscale image, and it could be misleading.
Despite the elaborate anatomic information provided by IVUS, there are some technical limitations, including the inability to deliver the catheter to the region of interest in tortuous vessels, through high-grade or calcified stenoses, and in smaller epicardial arteries. Other limitations include non-uniform rotational distortion (NURD) with mechanical IVUS transducers and distortion of the crosssectional image if the IVUS catheter image plane is not perpendicular to the long axis of the vessel (32 
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CAD ϭ coronary artery disease; FFR ϭ fractional flow reserve; IVUS ϭ intravascular ultrasound; MI ϭ myocardial infarction; MLA ϭ minimum lumen area; MLD ϭ minimum lumen diameter; rCFR ϭ relative coronary flow reserve; SPECT ϭ single-photon emission computed tomography; SVG ϭ saphenous vein graft. is the synthetic aperture device that has the transducer and multiplex transistors at the catheter tip. Because there is no mechanically rotating device shaft, the synthetic aperture ultrasound catheter passes over the wire through a central lumen. This facilitates maneuvering the catheter through more torturous anatomy. However, this benefit of ease of use comes with a consequence of lower power and inferior image quality.
CFR
Blood flow as volume/time cannot be measured directly in humans in the catheterization laboratory. The concept of CFR was introduced in the 1970s and is based on the principle that blood velocity is proportional to volume flow if the lumen area remains constant. The CFR is defined as the ratio of hyperemic mean blood velocity to resting blood velocity for a given Tobis et al. February 27, 2007:839-48 Assessment of Intermediate Coronary Lesions coronary artery (3, 33) . The CFR decreases with increased lesion severity (34) . Doppler-derived CFR measurements have been validated in the assessment of lesion severity, and a CFR value of Յ2.0 has been found to identify a hemodynamically significant stenosis (35) (36) (37) (38) (39) . Unfortunately, the CFR value is affected by both epicardial and microvascular resistance. Conditions such as diabetes, ventricular hypertrophy, and age can all affect CFR independent of the degree of epicardial coronary artery stenosis (40 -43) . The concept of relative CFR has been introduced to overcome some of the limitations associated with CFR in assessment of epicardial coronary artery stenosis. Relative CFR is obtained by dividing the CFR of the reference vessel by the CFR obtained in an adjacent "normal" coronary vessel. This requires interrogation of an additional coronary vessel (44) .
Because of the limitations in interpretation of CFR and relative CFR, neither of these modalities has gained widespread acceptance, and these techniques have been supplanted by the use of FFR.
FFR
One method of overcoming the limitations of coronary angiography is the use of invasive physiologic testing by the FFR technique to assess the functional significance of a coronary stenosis. The FFR is defined as the ratio of maximal blood flow achievable in a stenotic coronary artery relative to the maximal flow in the same vessel if it were normal (45-47) (Fig. 2) . A 0.014-inch pressure sensortipped coronary angioplasty guide wire is advanced across a stenosis, and the absolute distal pressure is recorded at rest and at maximal hyperemia induced with intracoronary or intravenous infusion of adenosine. Unlike CFR, FFR is independent of changes in heart rate, blood pressure, or prior infarction, and takes into account the contribution of collateral blood flow (46, 48) .
An FFR value of Ͻ0.75 correlates with ischemia on noninvasive stress tests (46, 47, 49, 50) . Several studies have demonstrated that in patients with an intermediate coronary lesion
and an FFR Ն0.75, PCI can safely be deferred (47, 51, 52) . Cardiac event rates are extremely low in this cohort of patients and even lower than that predicted if a PCI with a bare metal stent had been performed owing to the lack of restenosis in the deferred treatment group (52, 53) . The FFR is lesion specific and can be performed in patients with both single-or multivessel CAD (54) . Once a PCI is performed, adequacy of the PCI result can be assessed by FFR with established criteria for a successful balloon angioplasty (FFR Ն0.90) and stent placement (FFR Ն0.94) (55). Significant abnormal distal coronary pressure values after stenting predict adverse events at follow-up (56, 57) .
Attaining maximum vasodilation is critical for the accuracy of FFR measurement. The lack of a maximum hyperemic response produces a lower pressure gradient across the lesion and therefore underestimates its severity (58) . There are various pharmacological agents that include adenosine, adenosine 5'-triphosphate (ATP), papaverine, and dobutamine that could be administered intravenously (IV) or intracoronary (IC) (59 -64) . Owing to the low cost and high safety profile, IC adenosine is used in the majority of FFR assessments. However, the assessment of long lesions with diffuse disease or multiple lesions require a steady state induced by either IV adenosine or ATP or IC papaverine for the pressure pull-back maneuver (62, 63) .
Studies have shown that occlusion of an epicardial coronary artery leads to perivascular edema and capillary leukocyte plugging that prevents full restoration of myocardial perfusion (65) . The FFR is limited in the presence of this microvascular dysfunction observed in AMI. In these patients the FFR is overestimated, given that the ratio is measured in reference to maximum hyperemia at the level of the epicardial coronary artery with the assumption that the microvasculature is intact.
Lesion Assessment in Specific Lesion Subsets
Left main coronary artery stenosis. Left main coronary artery stenosis, as defined by a diameter stenosis on coronary angiography of Ն50%, is found in 5% of diagnostic coronary angiograms (66) . Assessment of left main CAD can be one of the most challenging lesion subsets for angiographers. In the CASS (the Coronary Artery Surgery Study) trial, when one observer reported Ն50% left main coronary artery stenosis, a second angiographer reported no stenosis 19% of the time (27) .
The FFR has been evaluated in a subset of patients with left main coronary artery stenosis. In 1 study, an FFR of Ͼ0.75 was associated with excellent 3-year survival and freedom from major adverse cardiovascular events (MACE) (67) . Similarly, a study of 122 patients by Abizaid et al. (68) demonstrated that patients with a left main minimum lumen diameter (MLD) Ͼ3.0 mm determined by IVUS had a very low 1-year event rate of 3%. Two recent studies of ambiguous left main coronary artery stenosis have shown a good correlation between IVUS and FFR in detection 
of hemodynamically significant CAD of the left main coronary artery (69, 70) . A cutoff value of 5.9 mm 2 was found to correlate best with an FFR of Ն0.75 (70) .
If angioplasty of the left main artery is being considered, we prefer using IVUS beforehand to assess the anatomy, the size of the vessels, and determine whether both left anterior descending and circumflex ostia are involved. The IVUS also reveals the extent of calcification and can be useful in deciding whether the lesion should be prepared with rotational atherectomy to facilitate placement of the stent. Assessment of serial stenoses within a single coronary artery. Patients with CAD often have multiple stenoses within a single coronary artery, 1 or more of which might be an intermediate coronary lesion. Both IVUS and FFR can assist in the determination of the clinical significance of each lesion as well as the optimal treatment strategy.
One study has demonstrated that FFR can accurately determine the hemodynamic significance of serial coronary lesions when performed via a slow "pull back method" during continuous intravenous infusion of adenosine. The findings of the pullback method were validated in the same study when PCI of 1 of the 2 lesions (the more hemodynamically significant lesion) was performed. The information provided could lead to avoidance of unnecessary procedures that increase the restenosis risk without providing a hemodynamic benefit (71) .
Intravascular ultrasound also assists in the assessment of serial stenosis within a single coronary artery. During a continuous mechanical pullback of the IVUS catheter, the images provide detailed anatomical information on the extent and characteristics of each arterial cross section. Intravascular ultrasound helps determine which lesions along the length of the artery are anatomically significant and therefore what length of artery needs to be treated with a stent. However, the hemodynamic status along the length of the artery in question cannot be determined by IVUS pullback alone. Coronary bypass grafts. By 5 years after coronary artery bypass graft surgery, vein graft disease affects 48% of grafts and 81% at 15 years (72). However, treatment of degenerated saphenous vein grafts (SVGs) by PCI is associated with a lower procedural success rate, a higher periprocedural complication rate, and a higher restenosis rate (73) (74) (75) (76) .
Saphenous vein grafts have a different ultrasonographic appearance compared with native coronary arteries. There are no side branches, and veins do not have an EEM; nevertheless, the extent of plaque can be easily identified by IVUS. Perhaps of greater importance, IVUS can characterize the quality of the tissue present and determine whether there is soft mobile material or thrombus in the graft. However, some SVG lesions, even in old grafts, might be fibrotic and are less likely to embolize when treated with PCI (74) . The pathogenesis of vein graft disease has been elucidated by IVUS (77, 78) . Early changes of wall thickening and adaptive remodeling predispose patients to subsequent atherosclerosis with occlusive plaque and constrictive or expansive remodeling (21, (77) (78) (79) . These findings correlate with histopathologic studies and in the future might establish windows for potential interventions. Currently, there are no clinical trials that evaluate the effectiveness of IVUS-guided PCI in patients with SVG disease (78) .
Provided the native vessel is occluded proximal to the anastamosis of the bypass graft, FFR across a bypass graft stenosis might provide an accurate reflection of the coronary flow at maximal hyperemia to the distal myocardial bed supplied by the bypass graft. There is a relative paucity of published reports that assesses the physiological significance of bypass graft stenoses. Currently, there are no clinical trials that evaluate the role of FFR in assessing the need for PCI in patients with SVG disease. However, 1 study evaluated Doppler flow velocity and myocardial perfusion single-photon emission computed tomography (SPECT) compared with angiography in assessment of SVG stenoses. Although there was a poor correlation between angiography and either SPECT or CFR, the latter 2 had an excellent correlation in the detection of ischemia (83%, kappa ϭ 0.61) (80) . Bifurcation lesions. Assessment of severity of coronary stenosis in bifurcation lesions as well as the performance of PCI in bifurcation lesions remains challenging (81) (82) (83) (84) (85) . Despite the emergence of DES, bifurcation lesions have a higher restenosis rate especially at the ostium of the side branch in comparison with simple lesions (85, 86 ). Angiographic assessment of the severity of bifurcation lesions is hampered by the inherent limitations of angiography, especially overlap of adjacent vessels, angulation, and foreshortening of the origin of the side branch (86) .
Intravascular ultrasound can be useful in the assessment of bifurcation lesions in determining the need for PCI (87) . Intravascular ultrasound can also assist in equipment selection and planning the PCI approach on the basis of the size of the vessels and the location of the plaque. It has been demonstrated that when the "crush technique" is used for bifurcation stenting, the smallest minimum stent area is typically at the ostium of the side branch, which might in part explain the higher restenosis rate observed at these locations (84) .
Physiologic determination of the hemodynamic significance of bifurcation lesions can also be reliably addressed with FFR. Separate FFR analysis of each branch can be performed to assess the hemodynamic significance of each stenosis and provides functional information that corresponds with morphological analysis (86) . Koo et al. (88) evaluated the feasibility and safety of physiological assessment of jailed side branches with FFR in 97 patients. The study demonstrated that no lesion with Ͻ75% stenosis by quantitative coronary angiography (QCA) had FFR Ͻ0.75 and among 73 lesions with Ͼ75% stenosis only 20 were functionally significant (88) . Thus, most of the lesions involving the jailed side branch might not have functional significance and do not require revascularization. Ziaee et al. (86) showed that 80% of patients with Ͼ70% stenosis of the (50) randomized 70 patients with ACS and moderate stenosis on angiography to decisions based on FFR versus myocardial scintigraphy and found that there was no significant difference between the 2 modalities in the frequency of event rates at 1-year. Another 2 observational studies that included a total of 42 patients with unstable angina or MI showed an 11% event rate at 1-year (96, 97) . These studies demonstrated the utility of FFR in deferring PCI in non-flow-limiting lesions in patients with ACS and avoiding unnecessary interventions that have a higher complication rate in these patients. Although there are no large randomized, controlled trials that have established the efficacy of FFR in patients with ACS, observational data described previously demonstrate that FFR provides complementary functional information that could be used in clinical decision-making in patients with ACS.
Intravascular ultrasound can also be performed safely in the setting of AMI (29) . Intravascular ultrasound can identify anatomically significant lesions, delineate extent of plaque burden, identify ulcerated or ruptured plaque, assess for presence and extent of intracoronary thrombus, distinguish arterial dissection from thrombosis, and assist in selection and sizing of equipment for performance of coronary intervention. Another important potential application of IVUS is identification of atheroma at risk for rupture on the basis of the echolucency, lipid-laden plaque, and expansive remodeling observed in ACS (32 (101) evaluated 14 patients diagnosed with ACS that were found to have a total of 28 ruptured plaques without critical stenoses in a nonculprit coronary artery on IVUS. The patients were treated medically and followed for a mean of 22 months. There were no significant cardiovascular events related to the lesion at follow-up, and 14 of 28 ruptured plaques healed with medical therapy. Another study conducted a subset analysis of 42 patients with unstable angina, showing that the presence of plaque ruptures on IVUS corresponded to elevated levels of creatine kinase (CK)-MB and increased rates of MACE (cardiac death, Q-wave MI, and target lesion revascularization) at 1-year follow-up (102) . Intravascular ultrasound provides critical information regarding the pathogenesis of atherosclerosis, plaque remodeling, and has demonstrated benefit in guiding therapy in small trials in patients with ACS.
The no-reflow phenomenon, defined by the acute reduction in coronary flow in the setting of a patent epicardial coronary artery is an uncommon complication of PCI (0.6% to 2.0%) (103) . More frequently, it occurs during rotational atherectomy, interventions involving SVGs, and AMI (103) . Up to 30% of PCIs performed in the setting of AMI are complicated by the "no-reflow" phenomenon where no blood flow proceeds distally despite a successful balloon dilatation or stent insertion (104, 105) . Although, the precise pathophysiology of no-reflow is still uncertain, various mechanisms, including microvascular spasms, distal embolization of thrombus or atherosclerotic debris, oxygen-free radical-mediated endothelial injury, or capillary inflammatory injury have been proposed (103) . Intravascular ultrasound can predict lesions at higher risk for "no-reflow" after PCI, owing to the plaque mass and loose tissue components of the plaque (105) . In addition, IVUS can rule out other causes of poor flow after PCI such as coronary dissection or residual stenosis (106) . Ostial lesions. Analogous to assessment of lesion severity in bifurcation stenoses, assessment of ostial lesion severity is confounded by vessel overlap with the aorta, angulation, and deep seating of the catheter beyond the ostial lesion (107) . In a study of 46 patients where 55 ostial lesions were evaluated, 20 of 25 patients (80%) determined to have stenosis severity of 70% or greater had an FFR Ն0.75 (86) . Although sensitivity of angiography in this study was 100%, the specificity was only 55%; there was an excellent correlation between presence of ischemia by noninvasive stress imaging studies and FFR.
Intravascular ultrasound is also helpful for diagnosing and treating ostial lesions. Intravascular ultrasound can delineate the extent of stenosis as well as the plaque burden at the ostial location, although heavy calcification limits the penetration of the ultrasound images. Precise placement of the stent at the aorta-ostial juncture is often challenging when using fluoroscopic guidance. The corresponding position of the IVUS catheter on the fluoroscopic image at the cross section where the ostium is observed on the ultrasound image can be very useful in ensuring correct stent placement. Without moving the image intensifier, the stent is placed in the same position as the IVUS catheter was when the aorta-ostial juncture was seen by ultrasound. After PCI, IVUS is helpful to confirm that the entire ostium has been covered by the stent, which will decrease the chance of restenosis.
Comparison of IVUS and FFR
Although IVUS does not provide direct estimation of the hemodynamic severity of a coronary lesion, several studies have demonstrated a strong correlation between anatomic data obtained from IVUS and ischemia by myocardial perfusion SPECT imaging (108), CFR (109), and FFR (110, 111 2 . By providing precise information on vessel size, extent of the atherosclerosis, and plaque characteristics, IVUS images help guide PCI strategy, equipment selection, and assessment of the adequacy of the results.
Fractional flow reserve provides important physiologic information on the hemodynamic severity of a coronary lesion and is helpful in the cardiac catheterization laboratory to determine whether PCI should be performed without stopping the procedure and sending the patient for a noninvasive stress test. Fractional flow reserve is easy to perform and provides an accurate and lesion-specific index of functional severity of coronary stenosis that correlates with noninvasive tests of myocardial ischemia in patients with intermediate lesions (112) . Fractional flow reserve has been compared with IVUS as a measurement for optimal stent deployment. One retrospective analysis showed that FFR Ն0.94 after stent deployment had a concordance rate of 91% with IVUS and displayed accuracy in guiding stent deployment (55) . However, another study revealed that FFR Ն0.96 did not reliably predict an optimum stent result (113) . The correlation between adverse outcomes after angioplasty and stenting and the FFR index has been evaluated. Bech et al. (114) , in 60 patients, showed excellent clinical outcomes at 2 years in patients with diameter stenosis Յ35%, and FFR Ն0.90. Pijls et al. (56) showed that a post-stent FFR Ն0.90 was associated with low incidence of the composite end point of death, MI, or total vessel revascularization at 6 months.
The heterogeneity of the patients studied in the multiple registries and differences in methodology between studies create difficulty in evaluating the efficacy of IVUS and FFR in specific clinical settings. There are no randomized, controlled trials to demonstrate the superiority of FFR versus IVUS in providing improved clinical outcomes in comparison with angiography alone. However, the issue of superiority might be irrelevant, because IVUS and FFR are complementary techniques that are used in the catheterization laboratory to provide critical anatomic and functional data that permit more accurate decisions in the management of the patient. In our laboratory, both methods are used: FFR is preferred to identify whether an intermediate lesion is functionally significant, and IVUS is preferred when assessing the anatomy of a lesion for sizing, position of plaque, and adequacy of stent deployment. 
